Öztürk, LeventÜnal, MuratTamer, LülüferÇelikoğlu, Firuz2019-06-272019-06-272003770886-44700886-4470https://hdl.handle.net/20.500.12469/184https://doi.org/10.1001/archotol.129.5.538Objective: To examine whether circulating leptin levels correlate with the severity of disease in patients with obstructive sleep apnea. Design: Prospective nonrandomized study. Setting: Referral sleep laboratory for patients with sleep-disordered breathing and biochemistry laboratory. Patients: Thirty-two subjects (mean+/-SD age 47+/-12 years) who were referred for suspected sleep apnea underwent an overnight sleep study and fasting morning venous blood sampling. Patients were divided into 3 groups with respect to apnea-hypopnea index: (1) severe sleep apnea (n=8) apnea-hypopnea index greater than 20(2) mild sleep apnea (n=12) apnea-hypopnea index between 5 and 20and (3) nonapneic control (n=12) apnea-hypopnea index less than 5. Results: Leptin levels (mean+/-SD) were 21.2+/-8.6 16.2+/-5.2 and 10.6+/-7.5 ng/mL (P=.005) inpatients with severe and mild obstructive sleep apnea and nonapneic controls respectively. Plasma leptin levels correlated positively with the degree of sleep-disordered breathing as recorded by the apnea-hypopnea index (r=0. 54 P=.001) and percentage of sleep time spent with oxygen saturation below 90% (r=0.39 P=.02). Conclusions: Circulating leptin concentrations in patients with obstructive sleep apnea independent of body mass index and age are significantly higher than levels in nonapneic controls and there is a positive relationship between leptin concentrations and the severity of sleep apnea. Hyperleptinemia may be a prognostic marker of obstructive sleep apnea syndrome.eninfo:eu-repo/semantics/openAccessArticle5385405129WOS:00018275630000410.1001/archotol.129.5.5382-s2.0-0038630630N/AN/A12759266